HOTH Similar Chart Price Prediction
The price of HOTH is predicted to go up -2.5%, based on the high correlation periods with DWSN. The similarity of these two price pattern on the periods is 98.28%.
HOTH
DWSN
Down: -2.5%Similarity: 98.28%
HOTH Revenue Forecast
HOTH EPS Forecast
HOTH FAQs
What is bull’s view on HOTH?
What is bear's view on HOTH?
HOTH Analyst's Forecast
Jason Kolbert
D. Boral Capital
Strong Buy
2025-01-07
Price Target
$5
Upside
+119.3%
After Hoth Therapeutics announced interim results from its Phase 2a CLEER-001 trial evaluating HT-001, a treatment for skin toxicities caused by Epidermal Growth Factor Receptor Inhibitors, D. Boral Capital noted that the open-label trial reported 100% of patients achieving the primary efficacy endpoint, which the analyst argues "highlight HT-001's potential to revolutionize care for patients facing debilitating side effects from cancer treatments." The firm maintains a Buy rating and $5 price target on Hoth shares.
